Glenmark Pharmaceuticals
GLENMARK.NS
#4116
Rank
$1.50 B
Marketcap
$5.34
Share price
0.99%
Change (1 day)
-20.06%
Change (1 year)

Earnings for Glenmark Pharmaceuticals (GLENMARK.NS)

Earnings in 2022 (TTM): $0.22 B

According to Glenmark Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are $0.22 B. In 2021 the company made an earning of $0.24 B an increase over its 2020 earnings that were of $0.23 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Glenmark Pharmaceuticals from 2012 to 2022

Annual earnings

Year Earnings Change
2022 (TTM)$0.22 B-8.57%
2021$0.24 B4.71%
2020$0.23 B18.75%
2019$0.19 B-14.84%
2018$0.22 B36.01%
2017$0.16 B-32.45%
2016$0.25 B66.83%
2015$0.14 B8.58%
2014$0.13 B-18.39%
2013$0.16 B3.67%
2012$0.16 B